Recursion Pharmaceuticals (RXRX) is back in focus after management detailed AI driven gains in drug discovery, including 25 new targets identified at once, as investors look ahead to an earnings ...
Recursion Pharmaceuticals, Inc. (RXRX) 25th Annual Needham Virtual Healthcare Conference April 13, 2026 12:45 PM EDTCompany ParticipantsBen Taylor - ...
Recursion Pharmaceuticals expanded its collaboration with Citeline to integrate real world data into its AI enabled ClinTech Platform. The partnership is aimed at refining clinical trial design and ...
Opinion
5dOpinion
To be human is to live with friction. That’s something AI boosters will never understand
We’re being sold a world where there’s no room for reflection or spontaneity. This is the Black Mirror stage of capitalism, says Alexander Hurst, who writes for Guardian Europe from Paris ...
Stanford's James Zou targets $1B valuation for AI physiology startup backed by Nature-published research and FDA-cleared cardiac AI ...
As Project Hail Mary grips audiences with its mix of science and survival, these five gripping novels offer more journeys ...
As AI tools like OpenAI’s GPT-5.5 and Anthropic’s Claude Design expand capabilities in coding and visual creation, experts warn of a homogenization of ideas and loss of creative distinction. Studies ...
At the start of Ben Lerner's startling new novel "Transcription," a man sits on a train trying to read and failing because he ...
The big SpaceX IPO is coming, and it could probably become the new, more exciting way to bet on Elon Musk’s vision of the ...
Security researchers have discovered 10 new indirect prompt injection (IPI) payloads targeting AI agents with malicious ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results